Nonadherence to immunosuppression: Challenges and solutions

Transplant Research and Risk Management

Volumn 7, Issue , 2015, Pages 27-34

  Moreso, Francesc ^a   Torres, Irina B ^a   Costa Requena, Gemma ^a   Serón, Daniel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Immunosuppressive treatment; Nonadherence; Renal transplantation

Indexed keywords

TACROLIMUS;

BASEL ASSESSMENT OF ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATION SCALE; CLINICAL OBSERVATION; CLINICAL TRIAL (TOPIC); COLLATERAL REPORTING; DEPRESSION; DISEASE ASSOCIATION; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MONITORING; GRAFT FAILURE; HEALTH BELIEF; HEALTH CARE ACCESS; HEALTH EDUCATION; HELPING HAND DATA CAPTURING; HUMAN; IMMUNOSUPPRESSIVE THERAPY ADHERENCE SCALE; IMMUNOSUPPRESSIVE TREATMENT; INTERPERSONAL COMMUNICATION; KIDNEY TRANSPLANTATION; MEDICATION COMPLIANCE; MEDICATION EVENT MONITORING SYSTEM; META ANALYSIS (TOPIC); MOTIVATION; MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SELF REPORT; SOCIOECONOMICS; SYSTEMATIC REVIEW (TOPIC); TREATMENT REFUSAL;

EID: 84931273845     PISSN: None     EISSN: 11791616     Source Type: Journal    
DOI: 10.2147/TRRM.S50796     Document Type: Review

References (35)

1. Sabaté E. Adherence to Long-Term Therapies. Evidence for Action. Switzerland: World Health organization; 2003.
2. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant. 2009;9:35-41.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341: 1725-1730.
4. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873.
5. Butler JA, Roderick P, Mullere M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77:769-789.
6. Hillbrands LB, Hoistma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation. 1995;60:914-920.
7. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppression. Transplantation. 2000;70:1240-1244.
8. Teixeira-De Barros C, Cabrita J. Noncompliance with immunosuppressive therapy: prevalence and determinants. Transplant Proc. 2000;32:2633.
9. Schäfer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616-626.
10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
11. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59(1):13-20.
12. Dobbels F, Lut B, De Geest S, et al; Transplant360 Task Force. The psychometric properties and practicability of self-report instruments to identify medication non-adherence in adult transplant patients to date: a systematic review. Transplantation. 2010;90(2):205-219.
13. De Geest S, Abraham I, Dunbar-Jacob J. Measuring transplant patients' compliance with immunosuppressive therapy. West J Nurs Res. 1996;18(5):595-605.
14. de Oliveira Marsicano E, da Silva Fernandes N, Colugnati F, et al. Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol. 2013;14:108.
15. Morris PJ. Transplantation - a medical miracle of the 20th century. N Engl J Med. 2004;351:2678-2680.
16. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363:1451-1462.
17. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001;60:1565-1570.
18. Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388-399.
19. Gaynor JJ, Ciancio G, Guerra G, et al. Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study. Transplantation. 2014;97:925-933.
20. Denhaerynck K, Desmyttere A, Dobbels F, et al. Nonadherence with immunosuppressive drugs: US compared with European kidney transplant recipients. Prog Transplant. 2006;16(3):206-214.
21. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
22. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm. 2005;62(17):1775-1781.
23. Chisholm-Burns M, Pinsky B, Parker G, et al. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant. 2012;26:706-713.
24. Hugon A, Roustit M, Lehmann A, et al. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Transplantation. 2014;98:222-228.
25. Chilcot J, Spencer BWJ, Maple H, Mamode N. Depression and kidney transplantation. Transplantation. 2014;97:717-772.
26. Griva K, Davenport A, Harrison M, Newman SP. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs forgetfulness and clinical markers of medication intake. Ann Behav Med. 2012;44:85.
27. Weng FL, Chandwani S, Kurtyka KM, Zacker C, Chisholm-Burns MA, Demissie K. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. BMC Nephrol. 2013;14:261-270.
28. Kuypers DR, Peeters PC, Sennesael JJ, et al; ADMIRAD Study Team. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation. 2013;95(2):333-340.
29. Couzi L, Moulin B, Morin MP, et al. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation. 2013;95(2):326-332.
30. Doesch AO, Mueller S, Akyol C, et al. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug Des Devel Ther. 2013;7:1253-1258.
31. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence: a systematic review. Transpl Int. 2009;22(8):780-797.
32. Low JK, Williams A, Manias E, Crawford K. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrol Dial Transplant. 2014;pii:gfu204.
33. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant. 2013;9:2364-2373.
34. Joost R, Dörje F, Schvitulla J, Eckardt KU, Hugo C. Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrol Dial Transplant. 2014;29(8): 1597-1607.
35. Cleemput I, Kesteloot K, Vanrenterghem Y, De Geest S. The economic implications of non-adherence after renal transplantation. Pharmacoeconomics. 2004;22(18):1217-1234.